141 related articles for article (PubMed ID: 23474137)
21. Sulfasalazine-Induced Toxic Epidermal Necrolysis: A Challenging Case During the COVID-19 Pandemic.
Shahidi-Dadras M; Shahrigharahkoshan S; Yazdi E; Fatemi A; Mahboubi-Fooladi Z; Dadkhahfar S
Adv Emerg Nurs J; 2021 Jul-Sep 01; 43(3):194-197. PubMed ID: 34397495
[TBL] [Abstract][Full Text] [Related]
22. Desensitization to sulfasalazine.
Hessemer CA; Schinagl EF
Am J Gastroenterol; 1993 Mar; 88(3):460-1, 462. PubMed ID: 8094941
[No Abstract] [Full Text] [Related]
23. Sulfasalazine-induced hypersensitivity: a case report of DRESS syndrome.
Yeşilova Z; Kantarcioğlu M; Erçin CN; Safalioğlu M; Kilciler G; Koç E; Atli M; Uygun A
Turk J Gastroenterol; 2009 Dec; 20(4):298-9. PubMed ID: 20084578
[No Abstract] [Full Text] [Related]
24. Resolution of giant cell myocarditis after extended ventricular assistance.
Eid SM; Schamp D; Halushka MK; Barouch LA
Arch Pathol Lab Med; 2009 Jan; 133(1):138-41. PubMed ID: 19123727
[TBL] [Abstract][Full Text] [Related]
25. Hyperacute graft rejection during heart transplantation for giant cell myocarditis: a case report.
Mutijima E; Delbecque K; Defraigne JO; Bouillenne C; Damas P; Pierard L; Boniver J; de Leval L
Pathol Res Pract; 2010 Jun; 206(6):411-4. PubMed ID: 20089370
[TBL] [Abstract][Full Text] [Related]
26. Orthotopic cardiac transplantation for the treatment of progressive heart failure caused by idiopathic giant cell myocarditis.
Ito H; Hong RA
Int J Cardiol; 2007 Mar; 116(1):121-2. PubMed ID: 16844247
[TBL] [Abstract][Full Text] [Related]
27. Successful heart transplantation in a patient with histopathologically proven giant cell myocarditis.
Briganti E; Esmore DS; Federman J; Bergin P
J Heart Lung Transplant; 1993; 12(5):880-1. PubMed ID: 8241233
[No Abstract] [Full Text] [Related]
28. Serial right ventricular endomyocardial biopsy in rapid-onset severe heart failure due to giant cell myocarditis.
van Haelst PL; Brügemann J; Diercks GF; Suurmeijer A; van Veldhuisen DJ
Cardiovasc Pathol; 2006; 15(4):228-30. PubMed ID: 16844555
[TBL] [Abstract][Full Text] [Related]
29. Orbital myositis, vitiligo, and giant cell myocarditis.
Stevens AW; Grossman ME; Barr ML
J Am Acad Dermatol; 1996 Aug; 35(2 Pt 2):310-2. PubMed ID: 8698913
[TBL] [Abstract][Full Text] [Related]
30. Stevens-Johnson syndrome in association with hydroxychloroquine treatment for rheumatoid arthritis.
Leckie MJ; Rees RG
Rheumatology (Oxford); 2002 Apr; 41(4):473-4. PubMed ID: 11961185
[No Abstract] [Full Text] [Related]
31. Anticonvulsant hypersensitivity syndrome leading to reversible myocarditis.
Zaidi AN
Can J Clin Pharmacol; 2005; 12(1):e33-40. PubMed ID: 15725647
[TBL] [Abstract][Full Text] [Related]
32. Giant cell myocarditis--a case report.
Lazar A; Frasik W; Garlicki M; Wierzbicki K; Stachura J; Dziatkowiak A
Pol J Pathol; 2001; 52(4):221-3. PubMed ID: 11915185
[TBL] [Abstract][Full Text] [Related]
33. T-cell receptor and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: understanding a hypersensitivity reaction.
Ko TM; Chen YT
Expert Rev Clin Immunol; 2012 Jul; 8(5):467-77. PubMed ID: 22882221
[TBL] [Abstract][Full Text] [Related]
34. Orbital inflammatory disease: unusual presentation of enthesitis in an HLA-B27 spondyloarthropathy.
Sachdeva A; Kramer N; Rosenstein ED
Ocul Immunol Inflamm; 2012 Dec; 20(6):468-70. PubMed ID: 23163732
[TBL] [Abstract][Full Text] [Related]
35. [Case of giant cell myocarditis].
Miroliubova OA; Supriadkina TV; Konopleva LV; Vasilev IaV
Klin Med (Mosk); 2008; 86(6):70-2. PubMed ID: 18720717
[TBL] [Abstract][Full Text] [Related]
36. [Experiences with infliximab in the treatment of active rheumatoid arthritis and spondyloarthropathy].
Dahlin J; Sørensen SF
Ugeskr Laeger; 2003 Nov; 165(48):4646-9. PubMed ID: 14677464
[No Abstract] [Full Text] [Related]
37. Rituximab in recurrent idiopathic giant cell myocarditis after heart transplantation: a potential therapeutic approach.
Toscano G; Tartaro P; Fedrigo M; Angelini A; Marcolongo R
Transpl Int; 2014 May; 27(5):e38-42. PubMed ID: 24444397
[TBL] [Abstract][Full Text] [Related]
38. Sulfasalazine desensitization in children and adolescents with chronic inflammatory bowel disease.
Tolia V
Am J Gastroenterol; 1992 Aug; 87(8):1029-32. PubMed ID: 1353658
[TBL] [Abstract][Full Text] [Related]
39. Sulphasalazine-induced hypersensitivity syndrome: a relapsing disorder and the role of human herpes virus-6.
Short K; Syn WK; Haydon G
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):181-2. PubMed ID: 17273007
[No Abstract] [Full Text] [Related]
40. [DRESS syndrome to sulfasalzine].
Bourguignon R; Piérrard-Franchimont C; Paquet P; Piérard GE
Rev Med Liege; 2006 Sep; 61(9):643-8. PubMed ID: 17112165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
